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dreaded complication after coronary artery bypass grafting
(CABG). The surgical literature suggests an incidence
ranging from 0.7%1,2 to 2.3%.3 However, more recent
reports from the Society of Thoracic Surgeons (STS)
National Adult Cardiac Surgery Database report an overall
incidence for isolated CABG in 2007 of 0.3%, which had
decreased to 0.2% in the most recent 2014 report.4 Indeed,
despite the increasing risk profile of surgical patients in
recent years, the incidence of DSWI has not increased.5,6
This potentially life-threatening complication is associated
with the need for subsequent procedures, with higher
morbidity and higher early mortality—a mortality that
can range from 1.5% when occurring as an isolated
complication up to 46.3% when associated with multiple
other complications.7-9 The impact of DSWI on late
mortality is controversial and likely related to how patient
groups are defined and cared for in various health care
environments.8,10-12
The surgical literature is replete with studies defining the
risk factors for DSWI, with several validated risk scoring
systems of varying levels of accuracy.13 The most recent
STS Model for DSWI (one of the most accurate) reports a
C-statistic (measure of discrimination) of 0.686,4 which is
generally considered to lie in the ‘‘scarcely accurate’’
(0.5-0.7) range.14 The most commonly cited independent
risk factors include diabetes and obesity, with immunosup-
pression, heart failure, chronic obstructive pulmonary
disease, renal failure, peripheral vascular disease, smoking,
prolonged operating times, use of the internal thoracic
artery, blood transfusions, need for surgical reexploration,
and need for postoperative cardiopulmonary resuscitation
all being well documented in various series.13 More
recently, intriguing evidence has documented a possible
role for psychologic anxiety and depression—an area
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identify independent predictors of DSWI is obviously
limited by prevalence and sample size. However, the
impact of center-level factors cannot be overemphasized.
Shih and colleagues17 recently reported that in the state of
Michigan, the predicted risk of hospital-acquired infection
after CABG varied by 2.8% across centers (ie, patient level
factors), whereas the actual observed rates of infection
varied by 18.2%.17
It is in this regard that the report in this issue of the
Journal from Kieser and colleagues18 makes a somewhat
stunning contribution. Rather than applying statistical
modeling to their results to report risk factors, the authors
chose to chronicle their efforts to eliminate DSWI in the
face of a dedicated and unusual commitment to bilateral
internal thoracic artery (BITA) grafting, even in diabetic
patients. As noted by the authors, despite a wealth of
retrospective data documenting a long-term survival benefit
for BITA versus single internal thoracic artery (SITA)
grafting,19 use of BITA grafting in clinical practice is
remarkably uncommon—4% in North America, 12% in
Europe, and 30% in Japan.20 It is specifically the risk of
DSWI that has discouraged surgeons from using this
approach in diabetic patients. This trend persists,
despite increasing evidence that BITA grafting can be
accomplished in diabetic patients, using a skeletonized
harvesting approach, with no significantly increased risk
of DSWI, yet with a significant improvement in long-term
survival.21,22 Indeed, the aggressive and diffuse nature of
diabetic coronary atherosclerosis may make BITA
grafting specifically more suitable for the diabetic patient.
The increased risk of infection does not seem to equal the
survival benefit.
However, Kieser and colleagues18 were not satisfied to
merely accept the risks of DSWI, but rather embarked on
a journey to eliminate them, without compromising the
integrity of the revascularization offered to the patient. As
any good quality improvement effort to address a complex
multifactorial problem in cardiac surgery, the authors’
approach involved no less than 12 quality improvement
efforts to reduce infection, 8 of which are specifically
tracked in this report. Each one individually has a
reasonable evidence base. The cumulative impact was to
reduce the incidence of DSWI in the most recent 469 of
1001 CABG cases to zero. Two obvious questions
inevitably arise. First, is zero really zero? Although the
authors present interesting and somewhat compelling
evidence based on statistical modeling that the probabilitygery c November 2014
Kurlansky Editorial Commentaryof future infection based on the most recent algorithm is
extremely low, the point is somewhat moot. The reality is
that they were able to achieve an extremely low and
markedly reduced infection rate using BITA grafting 76%
of the time, and 35% of patients were diabetic. Whether
the number is truly zero, or just incredibly low, only time
will tell. Could the lower prevalence of insulin-dependent
diabetes (but not diabetes in general) and chronic
obstructive pulmonary disease in the ‘‘after change-point’’
patient group have played a role in the reduced infection
rate? Probably, although the size of the reduction seems
clearly out of proportion to the size of risk reduction. In
any event, their patients are benefitting from advanced
arterial revascularization without the traditionally reported
incidence of DSWI.
The second obvious question that arises is which
intervention is it that accounted for the decrease? A purist
might relish the opportunity to examine the impact of
each measure in isolation. Unfortunately, for the 8 measures
alone this would involve 255 possible combinations—for
all 12 no less than a staggering 4095—well beyond the
scope of any reasonable clinical investigation, especially
when exploring an outcome with an incidence in the 1%
range (or less). In reality, this is not what surgeons do.
We address a problem with the full vigor of available
knowledge. In fact, others have reported the success of
this ‘‘bundled’’ approach to reducing DSWI after cardiac
surgery.23What is more instructive than the actual measures
used is the process by which the authors addressed the topic.
Not satisfied with improvement, they persisted in their
efforts until they had, at least for now, eliminated the
problem. During the process, they then applied sophisti-
cated statistical modeling to attempt to retrospectively
analyze their process in an attempt to discern which element
seemed to have had the most profound impact. They then
used this information in an ongoing basis to change clinical
behavior. We might want to debate whether the incremental
potential survival benefit of BITA grafting in a given
vigorous, young, obese, diabetic woman might not warrant
the risk of DSWI, but the authors’ experience with this
group of patients certainly warrants caution. Perhaps
ironically, the long-term survival benefit of BITA versus
SITA grafting is less clear for women than it is for men.
In the largest series reported to date, which unfortunately
consisted of only 329 women, BITA grafting did not confer
a late survival benefit compared with SITA grafting in
propensity-matched female patients, even though operative
survival was better.24
In any event, it is not certain that what determines DSWI
in one center will necessarily be applicable to another. Even
large data repository reports like that from the STS may
have limited applicability to other patient populations.25
These large registry findings are certainly corroborated by
the hospital-level data reported by Shih and colleagues17The Journal of Thoracic and Carfrom the Michigan experience, which essentially teach us
that hospital-level, rather than patient-level factors account
for more of the variance in postsurgical infection. The true
message of Kieser and colleagues18—aside from the
definitively actionable information related to minimizing
the risk of DSWI while maintaining a commitment to
arterial revascularization—is that it is ultimately the
dedication to clinical improvement through rigorous
self-examination and evidence-based programmatic
adaptation that will drive surgical quality. Both her
professional colleagues and her patients are the true
beneficiaries.References
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